Novartis experimental prostate cancer drug gets FDA breakthrough designation
Novartis announced on Wednesday that the FDA granted Breakthrough Therapy designation to an experimental therapy that targets advanced castration-resistant prostate cancer.
via FOX NEWS https://ift.tt/3wEn1ge
No comments:
Post a Comment
Thanks for your comment reply within 24 hours